$JAZZ Company News There’s good news for speculative

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$JAZZ Company News

There’s good news for speculative growth traders 2:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 2:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 8:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 10:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 11:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 8:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 9:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 12:09 p.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 10:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 11:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 11:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 12:07 p.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 12:11 p.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 11:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 12:15 p.m. Sept. 17, 2012 - Val Brickates Kennedy


Pfizer: You Won't Fool Me Twice 1:28 a.m. Today - Seeking Alpha
Jazz Pharmaceuticals Up On Allergan, Inc. Rumor 2:53 p.m. Sept. 5, 2014 - benzinga.com
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future 6:05 p.m. Sept. 3, 2014 - GuruFocus.com
Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead 5:28 p.m. Sept. 3, 2014 - Investors Business Daily
Baidu, AerCap And Jazz Among Basing Top World Stocks 5:49 p.m. Aug. 29, 2014 - Investors Business Daily
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch 7:02 a.m. Aug. 27, 2014 - Investors Business Daily
Jazz Pharmaceuticals (JAZZ) Shares March Higher, Can It Continue? - Tale of the Tape 9:06 a.m. Aug. 21, 2014 - Zacks.com
JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition' 1:02 p.m. Aug. 19, 2014 - benzinga.com
Why Jazz Pharmaceuticals (JAZZ) Stock Is Gaining Today 12:54 p.m. Aug. 19, 2014 - TheStreet.com
Will This Coverage Initiation Help Jazz Pharmaceuticals (JAZZ) Stock Today? 9:27 a.m. Aug. 19, 2014 - TheStreet.com
Analysts' Actions: El Pollo Loco, Jazz Pharmaceuticals, SolarCity 8:43 a.m. Aug. 19, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Applied Materials, Pollo Loco, Dollar General, SolarCity, Urban Outfitters and More 7:47 a.m. Aug. 19, 2014 - 247WallSt.com
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins 12:46 p.m. Aug. 18, 2014 - Investors Business Daily
Jazz Pharmaceuticals Is Taking Two Routes To Growth 5:10 p.m. Aug. 15, 2014 - Investors Business Daily
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Insider Trading Alert - JAZZ, ATRO And RHI Traded By Insiders 11:45 a.m. Aug. 15, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Is Today's Momo Momentum Stock 9:51 a.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape 8:44 a.m. Aug. 14, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ) 3:55 p.m. Aug. 13, 2014 - TheStreet.com


Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 9:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 8:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 9:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 12:00 p.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 9:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 6:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 4:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 4:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 11:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 8:02 a.m. July 28, 2014 - BusinessWire - BZX
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 4:05 p.m. July 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 4:05 p.m. July 21, 2014 - BusinessWire - BZX
Critical Alerts For GoPro, Canadian Solar, Questcor Pharmaceuticals, Caesars Entertainment, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 8, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 181

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 122

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 203

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Notice: Humacyte Investors Should Act Now

Updated Category News Views 117

Understanding the Investigation into Humacyte Faruqi & Faruqi, LLP, a prominent national law firm specializing in securities litigation, is actively looking into potential claims related to Humacyte, Inc. (NASDAQ: HUMA). This investigation comes as a significant opportunity for investors who may have suffered losses exceeding $75,000 during certain periods of the...

Continue Reading
Marco's Pizza Partners with Karate Kid: Legends for Film Launch

Updated Category News Views 206

Marco's Pizza and Karate Kid: Legends Collaboration In an exciting move to engage fans, Marco's Pizza, one of the fastest-growing pizza franchises, has teamed up with Sony Pictures' Karate Kid: Legends. This collaboration aims to celebrate the cherished Karate Kid series with a mouthwatering promotion that promises to delight both pizza and movie enthusiasts. Delicious...

Continue Reading
Innovative Tactile Makeup Palette Supports Vision Impaired Users

Updated Category News Views 352

Introduction to an Inclusive Beauty Initiative Makeup has long been synonymous with beauty and self-expression, yet it has often excluded a significant segment of the population: those who are blind or have low vision. Recognizing this critical gap, the Shine Foundation has collaborated with Cheekbone Beauty to create a groundbreaking solution in the beauty...

Continue Reading
Carver Bancorp Appoints Donald Felix as New Leader

Updated Category News Views 196

Carver Bancorp Welcomes Donald Felix as President and CEO Carver Bancorp, Inc. has made a significant announcement: Donald Felix is now its President and CEO. This marks an important chapter for Carver, which is well-known for its dedication to supporting underserved communities. A Legacy of Service and Community Investment Established in 1948, Carver has consistently led...

Continue Reading
Navigating Merger Concerns with SpartanNash Company Insights

Updated Category News Views 258

Understanding the SpartanNash Merger Situation As the merger of SpartanNash Company (NASDAQ: SPTN) with C&S Wholesale Grocers unfolds, there’s considerable interest in the deal, which proposes a cash buyout of $26.90 per share for SpartanNash shareholders. This sort of transaction can be complex, and it prompts many to wonder whether the offer truly represents a fair...

Continue Reading